Related Experiment Video
Updated: May 18, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy
D Mullane1, L Williams, A Merwick
1Department of Neurology, St Vincent's University Hospital, Elm Park, Dublin 4.
Abstract:
Drug induced aseptic meningitis (DIAM) is an uncommon condition that can mimic infective conditions. DIAM has been recognized with various treatments including non-steroidal anti-inflammatory drugs, monoclonal antibodies and some antibiotics. We report a patient presenting with aseptic meningitis forty-eight hours after commencing a course of intravenous immunoglobulin (IVIG) treatment. It is important that physicians prescribing this medication are aware of this rare complication so the diagnosis can be made quickly and the patient is not exposed to unnecessary treatments.
Insights
Drug-induced aseptic meningitis (DIAM) is a rare condition that can mimic infections. This case highlights intravenous immunoglobulin (IVIG) as a potential cause, emphasizing prompt diagnosis to avoid unnecessary treatments.
Area of Science:
- Neurology
- Immunology
- Pharmacology
Background:
- Drug-induced aseptic meningitis (DIAM) is an uncommon adverse drug reaction.
- DIAM can present with symptoms mimicking infectious meningitis, complicating diagnosis.
- Various medications, including NSAIDs, antibiotics, and monoclonal antibodies, have been implicated in DIAM.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

